The Food and Drug Administration (FDA) seems confident in Mounjaro’s ability to help people who suffer from type 2 diabetes. Mounjaro is also known as Tirzepatide, and apart from offering treatment for those who suffer from type 2 diabetes, it shows the potential to support weight loss as well.
Mounjaro improves blood sugar levels, leading to enhanced well-being for those who deal with type 2 diabetes. The drug operates similarly for both gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). It acts as an analog that activates receptors for both GLP-1 and GIP, effectively managing blood sugar levels in diabetic patients. It is important to note that engaging in physical activity and following specific dietary plans are crucial to fully harness the effectiveness of the drug. In other words, there’s no use expecting Mounjaro to work for your condition if you regularly consume junk food and don’t get into physical exercise at all.
Using Mounjaro to overcome obesity?
Mounjaro, the drug approved in 2022 to treat type 2 diabetes, has shown remarkable weight-loss effects, reducing participants’ weight by over 20%. The FDA granted it a fast-track designation for obesity treatment, using data from the SURMOUNT-1 and SURMOUNT-2 trials. The fast-track designation allows for the rolling submission of trial data, expediting the review process and potentially allowing for a sooner approval date. With rising obesity rates and limited medical treatment options, Tirzepatide could be a game-changer in the obesity epidemic.
How does Mounjaro function?
Mounjaro functions similarly to glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP) in both cases. We’re talking about an analog that can effectively control blood sugar levels in people with diabetes by activating the GLP-1 and GIP receptors. We must reiterate the need to maintain a healthy diet and be physically active in order to get the full benefits of the medication.
If you suffer from type 2 diabetes, you must focus on maintaining a balanced and healthy diet. Choose whole grains such as brown rice and quinoa instead of refined carbohydrates. Include a variety of non-starchy vegetables such as leafy greens and broccoli. Incorporate lean sources of protein (poultry, fish, and legumes, for instance). You also need to use healthy fats in moderation, such as avocados and olive oil. It’s important to control portion sizes and monitor your carbohydrate intake to manage blood sugar levels effectively.
Obesity is very widespread in the US
Obesity is one of the concerning health issues for those who live in the United States. According to data from the Centers for Disease Control and Prevention (CDC), the prevalence of obesity among adults in the US has been steadily increasing over the years. As of 2020, the prevalence of obesity among adults was about 42.4%. This means that nearly half of all adults in the US can be classified as obese.
It’s important to keep in mind that obesity rates vary by age group and demographic factors. The highest rates of obesity are usually observed among middle-aged adults (40-59 years old, to be more precise). Additionally, there are disparities in obesity prevalence based on race and ethnicity. Non-Hispanic Black adults have the highest rates of obesity, and they are followed by Hispanic adults.
We should never underestimate the dangers of obesity, as we’re talking about a condition that poses numerous health risks. For instance, a person who is obese has an increased risk of developing chronic conditions such as type 2 diabetes, certain types of cancer, heart disease, and other related health complications. Addressing and preventing obesity remains a public health priority in the United States.
In a previous article, you can read about a comparison between Mounjaro and Ozempic, as the two drugs were compared in a study that involved more than 1,800 participants.
